Which has the lower trailing P/E, ANAB or HCSG?

ANAB has the lower trailing P/E: ANAB trades at 8.93 and HCSG at 12.43. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ANAB or HCSG?

Over the past five years, ANAB grew revenue faster — ANAB at a 18.60% CAGR versus HCSG at 2.29%.

Is ANAB or HCSG more profitable?

ANAB runs the higher net margin — ANAB at 82.37% versus HCSG at 6.59%.

How have ANAB and HCSG total returns compared?

Over the past 5 years, ANAB delivered 21.54% and HCSG delivered -2.00% annualized total return. Past performance doesn't predict future results.

AnaptysBio, Inc. (ANAB) vs Healthcare Services Group, Inc. (HCSG)

A side-by-side comparison of AnaptysBio, Inc. and Healthcare Services Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ANAB

AnaptysBio, Inc.

$1.42B

$47.93HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT

HCSG

Healthcare Services Group, Inc.

$1.46B

$21.25HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT

Total return — ANAB vs HCSG

growth of $100 · dividends reinvested · last 10y

ANAB +334.2% (+15.8%/yr)HCSG -36.0% (-4.4%/yr)ANAB compounded faster over this window

Log scale — wide-divergence pair

ANAB HCSG

ANAB vs HCSG: by the numbers

•HCSG is the larger company ($1.46B vs $1.42B market cap).
•ANAB trades at the lower trailing earnings multiple (8.93 vs 12.43 P/E), one valuation lens rather than an overall verdict.
•ANAB converts more revenue to profit (82.37% vs 6.59% net margin).
•ANAB grew revenue faster over the past five years (18.60% vs 2.29% CAGR).

Metrics side by side

Valuation

Metric	ANAB	HCSG
P/E ratio	8.93	12.43
Forward P/E	N/A	17.72
P/S ratio	5.97	0.78
P/B ratio	134.08	2.81
EV / EBITDA	11.45	9.00
FCF yield	1.27%	10.38%

Profitability

Metric	ANAB	HCSG
Gross margin	98.97%	17.33%
Operating margin	20.42%	7.03%
Net margin	82.37%	6.59%
ROE	1849.06%	23.70%
ROIC	47.55%	16.83%

Growth (annualized)

Metric	ANAB	HCSG
Revenue CAGR (5Y)	18.60%	2.29%
EPS CAGR (5Y)	N/A	-9.08%
FCF CAGR (5Y)	27.41%	-8.15%
Total return CAGR (5Y)	21.54%	-2.00%

Frequently asked

Which has the lower trailing P/E, ANAB or HCSG?: ANAB has the lower trailing P/E: ANAB trades at 8.93 and HCSG at 12.43. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ANAB or HCSG?: Over the past five years, ANAB grew revenue faster — ANAB at a 18.60% CAGR versus HCSG at 2.29%.
Is ANAB or HCSG more profitable?: ANAB runs the higher net margin — ANAB at 82.37% versus HCSG at 6.59%.
How have ANAB and HCSG total returns compared?: Over the past 5 years, ANAB delivered 21.54% and HCSG delivered -2.00% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANAB analysis Full HCSG analysis Interactive comparison tool

Dig into the metrics

AnaptysBio P/E ratio Healthcare Services P/E ratio AnaptysBio ROE Healthcare Services ROE AnaptysBio operating margin Healthcare Services operating margin AnaptysBio revenue growth Healthcare Services revenue growth AnaptysBio free cash flow Healthcare Services free cash flow

AnaptysBio & Healthcare Services appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.